APA (7th ed.) Citation

J, Y., SS, C., E, I., SR, S., K, L., CS, F., . . . JJ, G. (2026). Development of bicistronic plasmids and fusion proteins for clinical translation of tumor immune reprogramming. Molecular therapy. Advances, 34(2), 201708. https://doi.org/10.1016/j.omta.2026.201708

Chicago Style (17th ed.) Citation

J, Yang, et al. "Development of Bicistronic Plasmids and Fusion Proteins for Clinical Translation of Tumor Immune Reprogramming." Molecular Therapy. Advances 34, no. 2 (2026): 201708. https://doi.org/10.1016/j.omta.2026.201708.

MLA (9th ed.) Citation

J, Yang, et al. "Development of Bicistronic Plasmids and Fusion Proteins for Clinical Translation of Tumor Immune Reprogramming." Molecular Therapy. Advances, vol. 34, no. 2, 2026, p. 201708, https://doi.org/10.1016/j.omta.2026.201708.